About Us
Our Story
Our Essence
Code of Ethics and Conduct
Rankings and Awards
Corporate Governance and Compliance
Prati-Donaduzzi Organogram
Prati-Donaduzzi Compliance Program
Customer Relationship
Ombudsman
Innovation and R&D
Prati-Donaduzzi Corporate University
Products
Generics
Brands
Phytotherapy medicines
Multi-fractionable tablets
Dietary Supplements
Active Pharmaceutical Ingredients
Cannabis Products
Discontinuation
Projects
Sponsorship and Backing
Socioenvironmental Responsibility
Children in Sciences
Factory Tours
Career
Prati-Donaduzzi Culture
Benefits
Education
Internships
Register your CV
Press
News
Support
Contact
Contact us
New Business
Sales
CSC
Pharmacovigilance
Ombudsman
Reports
Terms and Conditions
Frequently Asked Questions
Location
Cannabidiol
Saturday, 28 January 2017 21:00
ANVISA statement to press on generic drugs
font size
decrease font size
increase font size
Print
Email
Full Note Available at:
https://goo.gl/m9fcCr
Read
3656
times
Tweet
Published in
Last News
More in this category:
« Prati-Donaduzzi opens registrations for Digital Inclusion Program
Prati-Donaduzzi opens compulsory internship applications »
back to top
About Us
Our Story
Our Essence
Code of Ethics and Conduct
Rankings and Awards
Corporate Governance and Compliance
Prati-Donaduzzi Organogram
Prati-Donaduzzi Compliance Program
Customer Relationship
Ombudsman
Innovation and R&D
Prati-Donaduzzi Corporate University
Products
Generics
Brands
Phytotherapy medicines
Multi-fractionable tablets
Dietary Supplements
Active Pharmaceutical Ingredients
Cannabis Products
Discontinuation
Projects
Sponsorship and Backing
Socioenvironmental Responsibility
Children in Sciences
Factory Tours
Career
Prati-Donaduzzi Culture
Benefits
Education
Internships
Register your CV
Press
News
Support
Contact
Contact us
New Business
Sales
CSC
Pharmacovigilance
Ombudsman
Reports
Terms and Conditions
Frequently Asked Questions
Location
Cannabidiol
https://www.instagram.com/p/CV25_L9szV1/